Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01259752
Other study ID # P080603
Secondary ID
Status Completed
Phase Phase 3
First received September 23, 2010
Last updated July 30, 2012
Start date January 2010
Est. completion date July 2012

Study information

Verified date June 2010
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

This is a multicenter prospective randomized superiority controlled trial comparing leg stockings and standard care to standard care of ankle sprain and testing the hypothesis that compression stockings enable to reduce the median of recovery from ankle sprain by at least 6 days.


Description:

Introduction: Ankle sprain is a frequently encountered trauma lesion in emergency departments and is associated with important health expenses. However, appropriate care of this trauma lesion remains a matter of debate.

Hypothesis: The tested hypothesis is that compression stockings enable to reduce the median of recovery from ankle sprain by at least 6 days.

Main end point: Delay to recovery of normal painless walking, without any analgesic drug consumption.

Secondary end points : Pain at rest and during walking using a visual analog pain scale, bimalleolar and middle-feet perimeters, number of days with analgesic drug consumption, observance analysis, patient's tolerance using a visual analog scale, delay to recover sport activities in the subgroup of patients having a regular sport activity.

Methods: Multicenter Prospective randomized superiority controlled trial comparing leg stockings and standard care to standard care of ankle sprain. Standard care include the RICE (Rest, Ice, Compression, Elevation) protocol at admission, immobilization with ankle bracing (3 to 6 week duration according to severity and clinical course), recommendation for walking (no weight baring, partial weight bearing, total weight bearing), administration of analgesic drugs. The medical device tested in the present study is class II compressive stockings (compression between 15 and 20 mmHg).

Number of patients: With an alpha risk of 5%, a beta risk of 5%, 70 patients should be included in each group to be able to detect a 6 day difference in the delay of recovery, defined as normal painless walking without any analgesic drug consumption, taking into consideration 10% of patients lost during follow up.

Criteria for inclusion: Recent (<48h) ankle sprain without fracture and without other traumatic lesions in adult patients aged between 18 and 55 years. Patients with limb arterial disease, diabetes, or any diseases expected to potentially interfere with recovery of walking, are excluded as well as pregnant women.

Study schedule: Inclusion during first visit to the emergency department, then at day 7, 15-21, 30-45, and 90. Phone call interviews are performed to define the more appropriate timing of the visits.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Recent (<48h) ankle sprain without fracture and without other traumatic lesions in adult patients aged between 18 and 55 years.

Exclusion Criteria:

- Patients with limb arterial disease, diabetes, or any diseases expected to potentially interfere with recovery of walking, are excluded as well as pregnant women

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
compression stockings
compression stockings
Other:
standard non compressive stockings
standard non compressive stockings

Locations

Country Name City State
France Pitié Salpetriere hospital Paris

Sponsors (3)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Pierre and Marie Curie University, Poitiers University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Delay to recovery of normal painless walking, without any analgesic drug consumption. up to 90 days No
Secondary Pain at rest using a visual analog pain scale at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
Secondary Bimalleolar perimeter at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
Secondary Number of days with analgesic drug consumption at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
Secondary Observance analysis Number of days actually wearing compression stocking and ankle bracing and taking analgesic drugs at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
Secondary Delay to recover sport activities in the subgroup of patients having a regular sport activity at each follow-up visit (D-7, D-15 to 21, D-30 to 45) and at the last follow-up visit (D-90) No
Secondary Pain during walking using a visual analog pain scale at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
Secondary middle-feet perimeter at each follow-up visit (D-7, D-15 to 21, D-30 to 45) No
See also
  Status Clinical Trial Phase
Completed NCT02246361 - Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Phase 4
Completed NCT01438905 - Effect of Joint Mobilization in the Treatment of Chronic Ankle Instability N/A
Recruiting NCT04095598 - Computed Tomography With Stress Maneuvers for Evaluation of Distal Tibiofibular Syndesmosis Instability (CTMETS)
Completed NCT01957215 - Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief Phase 4
Completed NCT01561365 - Applicability of the Ottawa Ankle Rules N/A
Not yet recruiting NCT01446341 - Cast Immobilization Versus Functional Therapy for Acute, Severe Lateral Ankle Sprains N/A
Completed NCT01255423 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain Phase 3
Completed NCT00797368 - Manual Therapy and Exercise Versus Home Exercises in the Management of Patients Status Post Ankle Sprain N/A
Completed NCT00573768 - Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain Phase 2
Completed NCT02324270 - Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain Phase 3
Completed NCT02433964 - Evaluation of Therapeutic Effects of LED (627 +/- 10nm) The Initial Phase of the Ankle Sprains Treatment N/A
Completed NCT00446797 - Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain Phase 4
Completed NCT02682303 - Effect of Elastic Bandage on Balance in Chronic Ankle Instability N/A
Completed NCT02330198 - Validation of the Foot and Ankle Ability Measure Tool in Finnish N/A
Completed NCT02097940 - Influence of Sensorimotor Treatment in the Balance of Soccer N/A
Completed NCT01423513 - Effects of Ankle Support on Muscle Activation and Function N/A
Completed NCT01449760 - Ankle Sprain Rehabilitation With the Wii Balance Board N/A
Recruiting NCT02945618 - Neurocryostimulation for Acute Lateral Ankle Sprain N/A
Recruiting NCT02491736 - Ketoprofen Gel vs Placebo in Children With Ankle Sprain Phase 4
Terminated NCT02729207 - Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain Phase 2